19.01.2015 Views

Surgical Catalog - BIOMET 3i

Surgical Catalog - BIOMET 3i

Surgical Catalog - BIOMET 3i

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Introduction<br />

Surface Technologies<br />

Fine micron features<br />

on the implant collar<br />

(1 - 3 microns) via dual<br />

acid-etching (DAE)<br />

The <strong>3i</strong> T3 ® Implant Family<br />

The <strong>3i</strong> T3 Implant represents the most recent advanced dental implant<br />

surface technology since the introduction of the NanoTiteImplant in<br />

2007. This latest surface technology is designed to deliver aesthetic<br />

results through tissue preservation.<br />

A contemporary hybrid surface is provided by complex multi-surface<br />

topography. In preclinical studies*, the <strong>3i</strong> T3 with DCD ® Surface<br />

demonstrated increased integration strength throughout the healing<br />

phase as compared to less complex surface topographies. 1<br />

Coarse micron feature:<br />

(10+ microns) via resorbable<br />

calcium phosphate media blast<br />

Fine micron feature:<br />

(1 - 3 microns) via dual<br />

acid-etching (DAE) on top<br />

of the blasted surface<br />

Option for nano-scale features along the full<br />

length of the implant.<br />

Osseointegration is achieved with initial bone-to-implant contact, a<br />

major contributor to the implant’s stability. 2 The specifications of the<br />

<strong>3i</strong> T3 Implant and surgical instrumentation are held to rigorous<br />

tolerances to provide a closely integrated implant-to-osteotomy fit,<br />

creating a dental implant system designed for primary stability.<br />

The seal integrity is provided by a stable, tight implant/abutment<br />

interface that can minimize abutment micromotion and reduce the<br />

potential for microleakage. 3 The seal strength is designed to reduce<br />

microleakage through exacting interface tolerances and maximized<br />

clamping forces.<br />

The<br />

Gold-Tite ® Screw increases implant/abutment<br />

clamping force by 113% as compared to a non-coated screw with the<br />

Certain ® Implant. 4 The patented Gold-Tite Surface lubrication allows the<br />

screw to rotate further, increasing clamping force and maximizing<br />

abutment stability. 5 Implants with integrated platform switching medialize<br />

the implant/abutment junction (IAJ) inward, creating a biologic width<br />

between connective tissue and the IAJ, helping to maintain bone levels. 6<br />

1. Davies JE † , Ajami E, Moineddin R, et al. The role of different scale ranges of surface implant topography on the stability of the bone/implant interface.<br />

Biomaterials 2013;34(14):3535-3546. Epub 2013 Feb 14.<br />

2. Meredith N. Assessment of implant stability as a prognostic determinant. Int J Prosthodont. 1998 Sep-Oct;11(5):491-501.<br />

3. Gubbi P † , Suttin Z † , Towse R † . Microgap analysis at the implant-abutment interface of various dental implant systems. Poster Presentation (P-98): Academy of<br />

Osseointegration 28th Annual Meeting, March 2013, Tampa, Florida, USA.<br />

4. Suttin Z †† , Towse R †† . Effect of abutment screw design on implant system seal performance. Presented at the European Association for Osseointegration, 20th<br />

Annual Scientific Meeting; October 2012; Copenhagen, Denmark. http://biomet<strong>3i</strong>.com/Pdf/Posters/P-450_Effect_of_Screw_Design_on_Implant_Seal.pdf<br />

5. Byrne D, Jacobs S, O’Connell B, Houston F, Claffey N. Preloads generated with repeated tightening in three types of screws used in dental implant assemblies.<br />

J. Prosthodont. 2006 May–Jun;15(3):164-171.<br />

6. Lazzara R † , Porter SS. Platform switching: A new concept in implant dentistry for controlling post-restorative crestal bone levels. Int J Perio Rest Dent.<br />

2006;26:9-17.<br />

† JE Davies and R. Lazzara have financial relationships with <strong>BIOMET</strong> <strong>3i</strong> LLC resulting from speaking engagements, consulting engagements and other retained<br />

services.<br />

†† Mr. Gubbi, Mr. Suttin and Mr. Towse contributed to the above research while employed by <strong>BIOMET</strong> <strong>3i</strong>.<br />

*Pre-clinical studies are not necessarily indicative of clinical results.<br />

vi

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!